Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease

Justin R. Boike*, Steven L. Flamm

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Transjugular intrahepatic portosystemic shunts is an established treatment for portal hypertensive complications. Advancements in technology and technique have led to novel indications, including treatment of chronic portal vein thrombosis and use before abdominal surgery to alleviate portal hypertensive complications. Use of TIPS can facilitate the embolization of large portal-systemic shunts to alleviate refractory hepatic encephalopathy owing to excessive portal shunting. Despite these advances, transjugular intrahepatic portosystemic shunts is an invasive procedure with risk for complications and should be performed at a center with expertise to ensure a successful patient outcome.

Original languageEnglish (US)
Pages (from-to)373-388
Number of pages16
JournalClinics in liver disease
Volume24
Issue number3
DOIs
StatePublished - Aug 2020

Keywords

  • Ascites
  • Hepatopulmonary syndrome
  • Hepatorenal syndrome
  • Portal hypertension
  • Portal vein thrombosis
  • Spontaneous portal systemic shunts
  • Transjugular intrahepatic portosystemic shunt
  • Varices

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease'. Together they form a unique fingerprint.

Cite this